Global Oncolytic Virus Therapy Market Size, Status and Forecast 2022

Published: Oct, 2017 | Pages: 108 | Publisher: QYResearch
Industry: Healthcare | Report Format: Electronic (PDF)

This report studies the global Oncolytic Virus Therapy market, analyzes and researches the Oncolytic Virus Therapy development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like

•	Crusade Laboratories
•	Genelux Corporation
•	Oncolytics Biotech
•	Oncos Therapeutics
•	Jennerex Biotherapeutics
•	Lokon Pharma
•	Merck
•	MultiVir
•	Oncolys BioPharma
•	BioVex
•	Cell Genesys
•	PsiOxus Therapeutics

Market segment by Regions/Countries, this report covers

•	United States
•	EU
•	Japan
•	China
•	India
•	Southeast Asia

Market segment by Type, the product can be split into

•	Onxy-15
•	RIGVIR
•	Talimogene laherparepvec (T-VEC)
•	Reolysin

Market segment by Application, Oncolytic Virus Therapy can be split into

•	Lung Cancer
•	Prostate Cancer
•	Melanoma
•	Brain Tumor
•	Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 Table of Contents

Global Oncolytic Virus Therapy Market Size, Status and Forecast 2022

1 Industry Overview of Oncolytic Virus Therapy
    1.1  Oncolytic Virus Therapy Market Overview
        1.1.1 Oncolytic Virus Therapy Product Scope
        1.1.2 Market Status and Outlook
    1.2 Global Oncolytic Virus Therapy Market Size and Analysis by Regions
        1.2.1 United States
        1.2.2 EU
        1.2.3 Japan
        1.2.4 China
        1.2.5 India
        1.2.6 Southeast Asia
    1.3 Oncolytic Virus Therapy Market by Type
        1.3.1 Onxy-15
        1.3.2 RIGVIR
        1.3.3 Talimogene laherparepvec (T-VEC)
        1.3.4 Reolysin
    1.4 Oncolytic Virus Therapy Market by End Users/Application
        1.4.1 Lung Cancer
        1.4.2 Prostate Cancer
        1.4.3 Melanoma
        1.4.4 Brain Tumor
        1.4.5 Others

2 Global Oncolytic Virus Therapy Competition Analysis by Players
    2.1 Oncolytic Virus Therapy Market Size (Value) by Players (2016 and 2017)
    2.2 Competitive Status and Trend
        2.2.1 Market Concentration Rate
        2.2.2 Product/Service Differences
        2.2.3 New Entrants
        2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
    3.1 Crusade Laboratories
        3.1.1 Company Profile
        3.1.2 Main Business/Business Overview
        3.1.3 Products, Services and Solutions
        3.1.4 Oncolytic Virus Therapy Revenue (Value) (2012-2017)
        3.1.5 Recent Developments
    3.2 Genelux Corporation
        3.2.1 Company Profile
        3.2.2 Main Business/Business Overview
        3.2.3 Products, Services and Solutions
        3.2.4 Oncolytic Virus Therapy Revenue (Value) (2012-2017)
        3.2.5 Recent Developments
    3.3 Oncolytics Biotech
        3.3.1 Company Profile
        3.3.2 Main Business/Business Overview
        3.3.3 Products, Services and Solutions
        3.3.4 Oncolytic Virus Therapy Revenue (Value) (2012-2017)
        3.3.5 Recent Developments
    3.4 Oncos Therapeutics
        3.4.1 Company Profile
        3.4.2 Main Business/Business Overview
        3.4.3 Products, Services and Solutions
        3.4.4 Oncolytic Virus Therapy Revenue (Value) (2012-2017)
        3.4.5 Recent Developments
    3.5 Jennerex Biotherapeutics
        3.5.1 Company Profile
        3.5.2 Main Business/Business Overview
        3.5.3 Products, Services and Solutions
        3.5.4 Oncolytic Virus Therapy Revenue (Value) (2012-2017)
        3.5.5 Recent Developments
    3.6 Lokon Pharma
        3.6.1 Company Profile
        3.6.2 Main Business/Business Overview
        3.6.3 Products, Services and Solutions
        3.6.4 Oncolytic Virus Therapy Revenue (Value) (2012-2017)
        3.6.5 Recent Developments
    3.7 Merck
        3.7.1 Company Profile
        3.7.2 Main Business/Business Overview
        3.7.3 Products, Services and Solutions
        3.7.4 Oncolytic Virus Therapy Revenue (Value) (2012-2017)
        3.7.5 Recent Developments
    3.8 MultiVir
        3.8.1 Company Profile
        3.8.2 Main Business/Business Overview
        3.8.3 Products, Services and Solutions
        3.8.4 Oncolytic Virus Therapy Revenue (Value) (2012-2017)
        3.8.5 Recent Developments
    3.9 Oncolys BioPharma
        3.9.1 Company Profile
        3.9.2 Main Business/Business Overview
        3.9.3 Products, Services and Solutions
        3.9.4 Oncolytic Virus Therapy Revenue (Value) (2012-2017)
        3.9.5 Recent Developments
    3.10 BioVex
        3.10.1 Company Profile
        3.10.2 Main Business/Business Overview
        3.10.3 Products, Services and Solutions
        3.10.4 Oncolytic Virus Therapy Revenue (Value) (2012-2017)
        3.10.5 Recent Developments
    3.11 Cell Genesys
    3.12 PsiOxus Therapeutics

4 Global Oncolytic Virus Therapy Market Size by Type and Application (2012-2017)
    4.1 Global Oncolytic Virus Therapy Market Size by Type (2012-2017)
    4.2 Global Oncolytic Virus Therapy Market Size by Application (2012-2017)
    4.3 Potential Application of Oncolytic Virus Therapy in Future
    4.4 Top Consumer/End Users of Oncolytic Virus Therapy

5 United States Oncolytic Virus Therapy Development Status and Outlook
    5.1 United States Oncolytic Virus Therapy Market Size (2012-2017)
    5.2 United States Oncolytic Virus Therapy Market Size and Market Share by Players (2016 and 2017)

6 EU Oncolytic Virus Therapy Development Status and Outlook
    6.1 EU Oncolytic Virus Therapy Market Size (2012-2017)
    6.2 EU Oncolytic Virus Therapy Market Size and Market Share by Players (2016 and 2017)

7 Japan Oncolytic Virus Therapy Development Status and Outlook
    7.1 Japan Oncolytic Virus Therapy Market Size (2012-2017)
    7.2 Japan Oncolytic Virus Therapy Market Size and Market Share by Players (2016 and 2017)

8 China Oncolytic Virus Therapy Development Status and Outlook
    8.1 China Oncolytic Virus Therapy Market Size (2012-2017)
    8.2 China Oncolytic Virus Therapy Market Size and Market Share by Players (2016 and 2017)

9 India Oncolytic Virus Therapy Development Status and Outlook
    9.1 India Oncolytic Virus Therapy Market Size (2012-2017)
    9.2 India Oncolytic Virus Therapy Market Size and Market Share by Players (2016 and 2017)

10 Southeast Asia Oncolytic Virus Therapy Development Status and Outlook
    10.1 Southeast Asia Oncolytic Virus Therapy Market Size (2012-2017)
    10.2 Southeast Asia Oncolytic Virus Therapy Market Size and Market Share by Players (2016 and 2017)

11 Market Forecast by Regions, Type and Application (2017-2022)
    11.1 Global Oncolytic Virus Therapy Market Size (Value) by Regions (2017-2022)
        11.1.1 United States Oncolytic Virus Therapy Revenue and Growth Rate (2017-2022)
        11.1.2 EU Oncolytic Virus Therapy Revenue and Growth Rate (2017-2022)
        11.1.3 Japan Oncolytic Virus Therapy Revenue and Growth Rate (2017-2022)
        11.1.4 China Oncolytic Virus Therapy Revenue and Growth Rate (2017-2022)
        11.1.5 India Oncolytic Virus Therapy Revenue and Growth Rate (2017-2022)
        11.1.6 Southeast Asia Oncolytic Virus Therapy Revenue and Growth Rate (2017-2022)
    11.2 Global Oncolytic Virus Therapy Market Size (Value) by Type (2017-2022)
    11.3 Global Oncolytic Virus Therapy Market Size by Application (2017-2022)

12 Oncolytic Virus Therapy Market Dynamics
    12.1 Oncolytic Virus Therapy Market Opportunities
    12.2 Oncolytic Virus Therapy Challenge and Risk
        12.2.1 Competition from Opponents
        12.2.2 Downside Risks of Economy
    12.3 Oncolytic Virus Therapy Market Constraints and Threat
        12.3.1 Threat from Substitute
        12.3.2 Government Policy
        12.3.3 Technology Risks
    12.4 Oncolytic Virus Therapy Market Driving Force
        12.4.1 Growing Demand from Emerging Markets
        12.4.2 Potential Application

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs Trend/Customer Preference
    13.3 External Environmental Change
        13.3.1 Economic Fluctuations
        13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix
    Methodology
    Analyst Introduction
    Data Source

List of Tables and Figures

    Figure Oncolytic Virus Therapy Product Scope
    Figure Global Oncolytic Virus Therapy Market Size (Million USD) (2012-2017)
    Table Global Oncolytic Virus Therapy Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Figure Global Oncolytic Virus Therapy Market Share by Regions in 2016
    Figure United States Oncolytic Virus Therapy Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Figure EU Oncolytic Virus Therapy Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Figure Japan Oncolytic Virus Therapy Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Figure China Oncolytic Virus Therapy Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Figure India Oncolytic Virus Therapy Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Figure Southeast Asia Oncolytic Virus Therapy Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Figure Global Oncolytic Virus Therapy Market Share by Type in 2016
    Figure Onxy-15 Market Size (Million USD) and Growth Rate (2012-2017)
    Figure RIGVIR Market Size (Million USD) and Growth Rate (2012-2017)
    Figure Talimogene laherparepvec (T-VEC) Market Size (Million USD) and Growth Rate (2012-2017)
    Figure Reolysin Market Size (Million USD) and Growth Rate (2012-2017)
    Figure Global Oncolytic Virus Therapy Market Share by Application in 2016
    Table Key Downstream Customer in Lung Cancer
    Figure Oncolytic Virus Therapy Market Size (Million USD) and Growth Rate in Lung Cancer (2012-2017)
    Table Key Downstream Customer in Prostate Cancer
    Figure Oncolytic Virus Therapy Market Size (Million USD) and Growth Rate in Prostate Cancer (2012-2017)
    Table Key Downstream Customer in Melanoma
    Figure Oncolytic Virus Therapy Market Size (Million USD) and Growth Rate in Melanoma (2012-2017)
    Table Key Downstream Customer in Brain Tumor
    Figure Oncolytic Virus Therapy Market Size (Million USD) and Growth Rate in Brain Tumor (2012-2017)
    Table Key Downstream Customer in Others
    Figure Oncolytic Virus Therapy Market Size (Million USD) and Growth Rate in Others (2012-2017)
    Table Oncolytic Virus Therapy Market Size (Million USD) by Players (2016 and 2017)
    Figure Oncolytic Virus Therapy Market Size Share by Players in 2016
    Figure Oncolytic Virus Therapy Market Size Share by Players in 2017
    Table Crusade Laboratories Basic Information List
    Table Oncolytic Virus Therapy Business Revenue (Million USD) of Crusade Laboratories (2012-2017)
    Figure Crusade Laboratories Oncolytic Virus Therapy Business Revenue Market Share in 2016
    Table Genelux Corporation Basic Information List
    Table Oncolytic Virus Therapy Business Revenue (Million USD) of Genelux Corporation (2012-2017)
    Figure Genelux Corporation Oncolytic Virus Therapy Business Revenue Market Share in 2016
    Table Oncolytics Biotech Basic Information List
    Table Oncolytic Virus Therapy Business Revenue (Million USD) of Oncolytics Biotech (2012-2017)
    Figure Oncolytics Biotech Oncolytic Virus Therapy Business Revenue Market Share in 2016
    Table Oncos Therapeutics Basic Information List
    Table Oncolytic Virus Therapy Business Revenue (Million USD) of Oncos Therapeutics (2012-2017)
    Figure Oncos Therapeutics Oncolytic Virus Therapy Business Revenue Market Share in 2016
    Table Jennerex Biotherapeutics Basic Information List
    Table Oncolytic Virus Therapy Business Revenue (Million USD) of Jennerex Biotherapeutics (2012-2017)
    Figure Jennerex Biotherapeutics Oncolytic Virus Therapy Business Revenue Market Share in 2016
    Table Lokon Pharma Basic Information List
    Table Oncolytic Virus Therapy Business Revenue (Million USD) of Lokon Pharma (2012-2017)
    Figure Lokon Pharma Oncolytic Virus Therapy Business Revenue Market Share in 2016
    Table Merck Basic Information List
    Table Oncolytic Virus Therapy Business Revenue (Million USD) of Merck (2012-2017)
    Figure Merck Oncolytic Virus Therapy Business Revenue Market Share in 2016
    Table MultiVir Basic Information List
    Table Oncolytic Virus Therapy Business Revenue (Million USD) of MultiVir (2012-2017)
    Figure MultiVir Oncolytic Virus Therapy Business Revenue Market Share in 2016
    Table Oncolys BioPharma Basic Information List
    Table Oncolytic Virus Therapy Business Revenue (Million USD) of Oncolys BioPharma (2012-2017)
    Figure Oncolys BioPharma Oncolytic Virus Therapy Business Revenue Market Share in 2016
    Table BioVex Basic Information List
    Table Oncolytic Virus Therapy Business Revenue (Million USD) of BioVex (2012-2017)
    Figure BioVex Oncolytic Virus Therapy Business Revenue Market Share in 2016
    Table Cell Genesys Basic Information List
    Table Oncolytic Virus Therapy Business Revenue (Million USD) of Cell Genesys (2012-2017)
    Figure Cell Genesys Oncolytic Virus Therapy Business Revenue Market Share in 2016
    Table PsiOxus Therapeutics Basic Information List
    Table Oncolytic Virus Therapy Business Revenue (Million USD) of PsiOxus Therapeutics (2012-2017)
    Figure PsiOxus Therapeutics Oncolytic Virus Therapy Business Revenue Market Share in 2016
    Table Global Oncolytic Virus Therapy Market Size (Million USD) by Type (2012-2017)
    Figure Global Oncolytic Virus Therapy Market Size Share by Type in 2012
    Figure Global Oncolytic Virus Therapy Market Size Share by Type in 2013
    Figure Global Oncolytic Virus Therapy Market Size Share by Type in 2014
    Figure Global Oncolytic Virus Therapy Market Size Share by Type in 2015
    Figure Global Oncolytic Virus Therapy Market Size Share by Type in 2016
    Figure Global Oncolytic Virus Therapy Market Size Share by Type in 2017
    Table Global Oncolytic Virus Therapy Market Size (Million USD) by Application (2012-2017)
    Figure Global Oncolytic Virus Therapy Market Size (Million USD) by Application in 2012
    Figure Global Oncolytic Virus Therapy Market Size (Million USD) by Application in 2013
    Figure Global Oncolytic Virus Therapy Market Size (Million USD) by Application in 2014
    Figure Global Oncolytic Virus Therapy Market Size (Million USD) by Application in 2015
    Figure Global Oncolytic Virus Therapy Market Size (Million USD) by Application in 2016
    Figure Global Oncolytic Virus Therapy Market Size (Million USD) by Application in 2017
    Table Top Consumer/End Users of Oncolytic Virus Therapy
    Figure United States Oncolytic Virus Therapy Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Table United States Oncolytic Virus Therapy Market Size (Million USD) by Players (2012-2017)
    Figure United States Oncolytic Virus Therapy Market Size Share by Players in 2016
    Figure United States Oncolytic Virus Therapy Market Size Share by Players in 2017
    Figure EU Oncolytic Virus Therapy Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Table EU Oncolytic Virus Therapy Market Size (Million USD) by Players (2012-2017)
    Figure EU Oncolytic Virus Therapy Market Size Share by Players in 2016
    Figure EU Oncolytic Virus Therapy Market Size Share by Players in 2017
    Figure Japan Oncolytic Virus Therapy Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Table Japan Oncolytic Virus Therapy Market Size (Million USD) by Players (2012-2017)
    Figure Japan Oncolytic Virus Therapy Market Size Share by Players in 2016
    Figure Japan Oncolytic Virus Therapy Market Size Share by Players in 2017
    Figure China Oncolytic Virus Therapy Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Table China Oncolytic Virus Therapy Market Size (Million USD) by Players (2012-2017)
    Figure China Oncolytic Virus Therapy Market Size Share by Players in 2016
    Figure China Oncolytic Virus Therapy Market Size Share by Players in 2017
    Figure India Oncolytic Virus Therapy Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Table India Oncolytic Virus Therapy Market Size (Million USD) by Players (2012-2017)
    Figure India Oncolytic Virus Therapy Market Size Share by Players in 2016
    Figure India Oncolytic Virus Therapy Market Size Share by Players in 2017
    Figure Southeast Asia Oncolytic Virus Therapy Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Table Southeast Asia Oncolytic Virus Therapy Market Size (Million USD) by Players (2012-2017)
    Figure Southeast Asia Oncolytic Virus Therapy Market Size Share by Players in 2016
    Figure Southeast Asia Oncolytic Virus Therapy Market Size Share by Players in 2017
    Figure Global Oncolytic Virus Therapy Market Size (Million USD) by Regions (2017-2022)
    Table Global Oncolytic Virus Therapy Market Size (Million USD) by Regions (2017-2022)
    Figure Global Oncolytic Virus Therapy Market Size Share by Regions in 2017
    Figure Global Oncolytic Virus Therapy Market Size Share by Regions in 2022
    Figure United States Oncolytic Virus Therapy Revenue (Million USD) and Growth Rate (2017-2022)
    Figure EU Oncolytic Virus Therapy Revenue (Million USD) and Growth Rate (2017-2022)
    Figure Japan Oncolytic Virus Therapy Revenue (Million USD) and Growth Rate (2017-2022)
    Figure China Oncolytic Virus Therapy Revenue (Million USD) and Growth Rate (2017-2022)
    Figure India Oncolytic Virus Therapy Revenue (Million USD) and Growth Rate (2017-2022)
    Figure Southeast Asia Oncolytic Virus Therapy Revenue (Million USD) and Growth Rate (2017-2022)
    Table Global Oncolytic Virus Therapy Market Size (Million USD) by Type (2017-2022)
    Figure Global Oncolytic Virus Therapy Market Size Share by Type in 2017
    Figure Global Oncolytic Virus Therapy Market Size Share by Type in 2022
    Table Global Oncolytic Virus Therapy Market Size (Million USD) by Application (2017-2022)
    Figure Global Oncolytic Virus Therapy Market Size (Million USD) by Application in 2017
    Figure Global Oncolytic Virus Therapy Market Size (Million USD) by Application in 2022